Literature DB >> 7018498

The location of drug binding sites in human serum albumin.

K J Fehske, W E Müller, U Wollert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7018498     DOI： 10.1016/0006-2952(81)90151-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  49 in total

1.  The in situ acetylation of an immobilized human serum albumin chiral stationary phase for high-performance liquid chromatography in the examination of drug-protein binding phenomena.

Authors:  T A Noctor; I W Wainer
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

2.  Albumin-based nanoparticles as magnetic resonance contrast agents: II. Physicochemical characterisation of purified and standardised nanoparticles.

Authors:  A A Abdelmoez; G C Thurner; E A Wallnöfer; N Klammsteiner; C Kremser; H Talasz; M Mrakovcic; E Fröhlich; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2010-07-14       Impact factor: 4.304

3.  Quantitative characterization of binding of small molecules to extracellular matrix.

Authors:  Yufen Zhang; Viera Lukacova; Katie Reindl; Stefan Balaz
Journal:  J Biochem Biophys Methods       Date:  2006-02-17

4.  Mode of interaction of loop diuretics with human serum albumin and characterization of binding site.

Authors:  N Takamura; A Haruta; H Kodama; M Tsuruoka; K Yamasaki; A Suenaga; M Otagiri
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

5.  Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation.

Authors:  M M Stollenwerk; I Pashkunova-Martic; C Kremser; H Talasz; G C Thurner; A A Abdelmoez; E A Wallnöfer; A Helbok; E Neuhauser; N Klammsteiner; L Klimaschewski; E von Guggenberg; E Fröhlich; B Keppler; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2010-02-20       Impact factor: 4.304

6.  The effect of octanoic acid on the binding of the enantiomers of ibuprofen and naproxen to human serum albumin: a chromatographic implication.

Authors:  V K Cheruvallath; C M Riley; S R Narayanan; S Lindenbaum; J H Perrin
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

7.  A re-evaluation of the HSA-piroxicam interaction.

Authors:  F Brée; S Urien; P Nguyen; P Riant; E Albengres; J P Tillement
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Oct-Dec       Impact factor: 2.441

8.  Molecular interaction of PCB180 to human serum albumin: insights from spectroscopic and molecular modelling studies.

Authors:  Senbiao Fang; Huanhuan Li; Tao Liu; Hongxia Xuan; Xin Li; Chunyan Zhao
Journal:  J Mol Model       Date:  2014-03-16       Impact factor: 1.810

9.  Characterization of a versatile organometallic pro-drug (CORM) for experimental CO based therapeutics.

Authors:  João D Seixas; Abhik Mukhopadhyay; Teresa Santos-Silva; Leo E Otterbein; David J Gallo; Sandra S Rodrigues; Bruno H Guerreiro; Ana M L Gonçalves; Nuno Penacho; Ana R Marques; Ana C Coelho; Patrícia M Reis; Maria J Romão; Carlos C Romão
Journal:  Dalton Trans       Date:  2013-05-07       Impact factor: 4.390

10.  In-vitro relationship between protein-binding and free drug concentrations of a water-soluble selective beta-adrenoreceptor antagonist (atenolol) and its interaction with arsenic.

Authors:  M A Alam; M A Awal; N Subhan; M Mostofa
Journal:  J Health Popul Nutr       Date:  2009-02       Impact factor: 2.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.